Corcept Therapeutics Stock Options
| CORT Stock | USD 22.80 0.59 2.66% |
Corcept Therapeutics' option chain provides insight into all available option contracts written on Corcept Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Corcept Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Corcept option contract.
In The Money vs. Out of Money Option Contracts on Corcept Therapeutics
Analyzing Corcept Therapeutics' in-the-money options over time can help investors to take a profitable long position in Corcept Therapeutics regardless of its overall volatility. This is especially true when Corcept Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Corcept Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Corcept Therapeutics' stock while costing only a fraction of its price.
Corcept Therapeutics' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 73.79 with a put-to-call open interest ratio of 0.9 over 66 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 78, with calls trading at the volume of 899. This yields a 0.09 put-to-call volume ratio. The Corcept Therapeutics option chain provides detailed quote and price information for the current Corcept Therapeutics Incorporated option contracts. It shows all of Corcept Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Corcept Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Corcept Therapeutics' lending market. For example, when Corcept Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Corcept Therapeutics, he or she must hedge the risk by shorting Corcept Therapeutics stock over its option's life.
2024-05-17
The chart above shows Corcept Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Corcept Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Corcept Therapeutics' option, there is no secondary market available for investors to trade.
Corcept Therapeutics Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Corcept Therapeutics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Corcept Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Corcept Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Corcept stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Corcept Therapeutics' stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corcept Therapeutics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. Please note that buying 'in-the-money' options on Corcept Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Corcept Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Corcept Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Corcept Stock moves the wrong way.
At this time, Corcept Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 652.6 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 98.3 M in 2024. Corcept Therapeutics In The Money Call Balance
When Corcept Therapeutics' strike price is surpassing the current stock price, the option contract against Corcept Therapeutics Incorporated stock is said to be in the money. When it comes to buying Corcept Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Corcept Therapeutics Incorporated are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Corcept Current Options Market Mood
Corcept Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Corcept Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Corcept Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Corcept Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Corcept Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Corcept contract
Base on the Rule 16, the options market is currently suggesting that Corcept Therapeutics Incorporated will have an average daily up or down price movement of about 4.61% per day over the life of the 2024-05-17 option contract. With Corcept Therapeutics trading at USD 22.8, that is roughly USD 1.05. If you think that the market is fully incorporating Corcept Therapeutics' daily price movement you should consider buying Corcept Therapeutics Incorporated options at the current volatility level of 73.79%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Corcept |
Purchasing Corcept Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Corcept calls. Remember, the seller must deliver Corcept Therapeutics Incorporated stock to the call owner when a call is exercised.
Corcept Therapeutics Option Chain
When Corcept Therapeutics' strike price is surpassing the current stock price, the option contract against Corcept Therapeutics Incorporated stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Corcept Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Corcept. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Corcept. It also shows strike prices and maturity days for a Corcept Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $11.0 | 0.8887 | 0.0078 | 0 | 2024-05-17 | 9.5 - 14.1 | 0.0 | In |
Call | 2024-05-17 CALL at $12.0 | 0.8769 | 0.0097 | 0 | 2024-05-17 | 8.5 - 12.9 | 0.0 | In |
Call | 2024-05-17 CALL at $13.0 | 0.8614 | 0.0113 | 0 | 2024-05-17 | 7.5 - 12.0 | 0.0 | In |
Call | 2024-05-17 CALL at $14.0 | 0.8445 | 0.0131 | 0 | 2024-05-17 | 6.5 - 11.1 | 0.0 | In |
Call | 2024-05-17 CALL at $15.0 | 0.9228 | 0.0189 | 209 | 2024-05-17 | 5.8 - 10.5 | 7.62 | In |
Call | 2024-05-17 CALL at $16.0 | 0.8084 | 0.0182 | 0 | 2024-05-17 | 4.5 - 9.1 | 0.0 | In |
Call | 2024-05-17 CALL at $17.0 | 0.9112 | 0.0292 | 0 | 2024-05-17 | 3.7 - 8.5 | 0.0 | In |
Call | 2024-05-17 CALL at $18.0 | 0.8778 | 0.039 | 0 | 2024-05-17 | 2.9 - 7.5 | 0.0 | In |
Call | 2024-05-17 CALL at $19.0 | 0.9207 | 0.0469 | 0 | 2024-05-17 | 1.75 - 6.2 | 0.0 | In |
Call | 2024-05-17 CALL at $20.0 | 0.773 | 0.0637 | 6 | 2024-05-17 | 3.1 - 4.0 | 2.88 | In |
Call | 2024-05-17 CALL at $21.0 | 0.7153 | 0.0839 | 36 | 2024-05-17 | 2.35 - 2.95 | 2.35 | In |
Call | 2024-05-17 CALL at $22.0 | 0.624 | 0.1004 | 96 | 2024-05-17 | 1.8 - 2.1 | 1.65 | In |
Call | 2024-05-17 CALL at $23.0 | 0.5177 | 0.1087 | 269 | 2024-05-17 | 1.3 - 1.5 | 1.15 | Out |
Call | 2024-05-17 CALL at $24.0 | 0.4128 | 0.1062 | 308 | 2024-05-17 | 0.9 - 1.2 | 1.0 | Out |
Call | 2024-05-17 CALL at $25.0 | 0.3097 | 0.0996 | 1996 | 2024-05-17 | 0.6 - 0.75 | 0.65 | Out |
Call | 2024-05-17 CALL at $26.0 | 0.2314 | 0.0846 | 1059 | 2024-05-17 | 0.4 - 0.5 | 0.45 | Out |
Call | 2024-05-17 CALL at $27.0 | 0.1789 | 0.0692 | 266 | 2024-05-17 | 0.3 - 0.35 | 0.34 | Out |
Call | 2024-05-17 CALL at $28.0 | 0.1189 | 0.0543 | 730 | 2024-05-17 | 0.15 - 0.25 | 0.2 | Out |
Call | 2024-05-17 CALL at $29.0 | 0.1001 | 0.0443 | 3348 | 2024-05-17 | 0.1 - 0.25 | 0.16 | Out |
Call | 2024-05-17 CALL at $30.0 | 0.1012 | 0.0393 | 303 | 2024-05-17 | 0.05 - 0.2 | 0.2 | Out |
Call | 2024-05-17 CALL at $31.0 | 0.1909 | 0.0401 | 36 | 2024-05-17 | 0.05 - 1.2 | 0.05 | Out |
Call | 2024-05-17 CALL at $33.0 | 0.0429 | 0.0198 | 1510 | 2024-05-17 | 0.05 - 0.1 | 0.1 | Out |
Call | 2024-05-17 CALL at $45.0 | 0.0211 | 0.0072 | 11 | 2024-05-17 | 0.0 - 2.0 | 0.05 | Out |
Put | 2024-05-17 PUT at $12.0 | -0.0271 | 0.0074 | 157 | 2024-05-17 | 0.0 - 0.1 | 0.1 | Out |
Put | 2024-05-17 PUT at $13.0 | -0.0303 | 0.0091 | 70 | 2024-05-17 | 0.0 - 0.1 | 0.1 | Out |
Put | 2024-05-17 PUT at $15.0 | -0.0645 | 0.0179 | 2696 | 2024-05-17 | 0.1 - 0.35 | 0.1 | Out |
Put | 2024-05-17 PUT at $16.0 | -0.0378 | 0.0169 | 244 | 2024-05-17 | 0.05 - 0.7 | 0.08 | Out |
Put | 2024-05-17 PUT at $17.0 | -0.078 | 0.0282 | 247 | 2024-05-17 | 0.1 - 0.6 | 0.2 | Out |
Put | 2024-05-17 PUT at $18.0 | -0.1133 | 0.0388 | 257 | 2024-05-17 | 0.25 - 0.3 | 0.3 | Out |
Put | 2024-05-17 PUT at $19.0 | -0.1437 | 0.0521 | 1131 | 2024-05-17 | 0.3 - 0.5 | 0.35 | Out |
Put | 2024-05-17 PUT at $20.0 | -0.2125 | 0.067 | 3154 | 2024-05-17 | 0.45 - 0.7 | 0.65 | Out |
Put | 2024-05-17 PUT at $21.0 | -0.2887 | 0.0826 | 103 | 2024-05-17 | 0.7 - 0.95 | 0.95 | Out |
Put | 2024-05-17 PUT at $22.0 | -0.3777 | 0.1 | 3067 | 2024-05-17 | 1.0 - 1.7 | 1.1 | Out |
Put | 2024-05-17 PUT at $23.0 | -0.4837 | 0.1082 | 668 | 2024-05-17 | 1.45 - 2.0 | 1.55 | In |
Put | 2024-05-17 PUT at $24.0 | -0.5995 | 0.113 | 104 | 2024-05-17 | 2.0 - 2.5 | 2.05 | In |
Put | 2024-05-17 PUT at $25.0 | -0.6088 | 0.0733 | 533 | 2024-05-17 | 2.55 - 4.3 | 3.3 | In |
Put | 2024-05-17 PUT at $26.0 | -0.709 | 0.0758 | 42 | 2024-05-17 | 2.2 - 5.6 | 4.25 | In |
Put | 2024-05-17 PUT at $27.0 | -0.7877 | 0.0681 | 33 | 2024-05-17 | 2.95 - 6.3 | 6.0 | In |
Put | 2024-05-17 PUT at $28.0 | -0.8506 | 0.0568 | 131 | 2024-05-17 | 5.1 - 5.8 | 5.98 | In |
Put | 2024-05-17 PUT at $29.0 | -0.8024 | 0.0499 | 24 | 2024-05-17 | 5.1 - 8.3 | 6.4 | In |
Put | 2024-05-17 PUT at $30.0 | -0.8038 | 0.0444 | 2 | 2024-05-17 | 6.0 - 9.5 | 8.12 | In |
Put | 2024-05-17 PUT at $31.0 | -0.8926 | 0.0361 | 0 | 2024-05-17 | 6.3 - 10.5 | 4.0 | In |
Put | 2024-05-17 PUT at $32.0 | -0.6915 | 0.0335 | 2795 | 2024-05-17 | 7.5 - 10.8 | 11.5 | In |
Put | 2024-05-17 PUT at $33.0 | -0.8898 | 0.0306 | 0 | 2024-05-17 | 8.4 - 12.5 | 0.0 | In |
Put | 2024-05-17 PUT at $34.0 | -0.894 | 0.0282 | 0 | 2024-05-17 | 9.4 - 13.5 | 0.0 | In |
Put | 2024-05-17 PUT at $35.0 | -0.8008 | 0.0302 | 150 | 2024-05-17 | 11.5 - 14.5 | 14.5 | In |
Put | 2024-05-17 PUT at $36.0 | -0.9124 | 0.0233 | 0 | 2024-05-17 | 11.3 - 15.5 | 0.0 | In |
Put | 2024-05-17 PUT at $37.0 | -0.9149 | 0.0218 | 0 | 2024-05-17 | 12.3 - 16.5 | 0.0 | In |
Put | 2024-05-17 PUT at $38.0 | -0.9061 | 0.0216 | 0 | 2024-05-17 | 13.4 - 17.5 | 0.0 | In |
Put | 2024-05-17 PUT at $39.0 | -0.9637 | 0.0126 | 0 | 2024-05-17 | 14.0 - 18.5 | 0.0 | In |
Put | 2024-05-17 PUT at $41.0 | -0.923 | 0.0175 | 0 | 2024-05-17 | 16.3 - 20.5 | 0.0 | In |
Put | 2024-05-17 PUT at $45.0 | -0.9179 | 0.0158 | 0 | 2024-05-17 | 20.4 - 24.5 | 0.0 | In |
Put | 2024-05-17 PUT at $50.0 | -0.9439 | 0.0115 | 0 | 2024-05-17 | 25.2 - 29.5 | 0.0 | In |
Corcept Therapeutics Common Stock Over Time
Common Stock |
| Timeline |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Corcept Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Corcept Therapeutics Corporate Directors
Corcept Therapeutics corporate directors refer to members of a Corcept Therapeutics board of directors. The board of directors generally takes responsibility for the Corcept Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Corcept Therapeutics' board members must vote for the resolution. The Corcept Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| David Mahoney | Independent Director | Profile | |
| Renee Gala | Director | Profile | |
| Len Baker | Independent Director | Profile | |
| George Baker | Independent Director | Profile |
Already Invested in Corcept Therapeutics Incorporated?
The danger of trading Corcept Therapeutics Incorporated is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Corcept Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Corcept Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Corcept Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Corcept Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Corcept Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Corcept Therapeutics Incorporated Stock. Highlighted below are key reports to facilitate an investment decision about Corcept Therapeutics Incorporated Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corcept Therapeutics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Corcept Stock analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Corcept Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corcept Therapeutics. If investors know Corcept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.995 | Earnings Share 0.94 | Revenue Per Share 4.658 | Quarterly Revenue Growth 0.314 | Return On Assets 0.1113 |
The market value of Corcept Therapeutics is measured differently than its book value, which is the value of Corcept that is recorded on the company's balance sheet. Investors also form their own opinion of Corcept Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Corcept Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corcept Therapeutics' market value can be influenced by many factors that don't directly affect Corcept Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corcept Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corcept Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corcept Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.